Related Experiment Videos

[New management strategies for hepatitis B]

Corinne Castelneau¹, Nathalie Boyer, Patrick Marcellin

¹Service d'Hépatologie, INSERM U-481 et Centre de Recherche Claude Bernard sur les Hépatites Virales, Hôpital Beaujon, Clichy, France.

Gastroenterologie Clinique Et Biologique

|April 9, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department.

Journal of viral hepatitis·2025

Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.

Alimentary pharmacology & therapeutics·2024

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.

American journal of human genetics·2024

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.

The American journal of gastroenterology·2023

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.

JHEP reports : innovation in hepatology·2023

Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.

Alimentary pharmacology & therapeutics·2022

See all related articles